T1	Concept 311 319	SARS-Cov
T2	Concept 324 332	MERS-Cov
T3	Concept 410 421	Gemcitabine
T4	Concept 682 690	SARS-CoV
T5	Concept 526 534	SARS-CoV
T6	Concept 152 161	2019-nCoV
T7	Concept 219 227	SARS-CoV
T8	Concept 201 205	S-29
T9	Concept 206 213	protein
R1	is-a Arg1:T8 Arg2:T9	
R2	has-part Arg1:T7 Arg2:T8	
T10	Concept 267 276	S-protein
T11	Concept 189 197	sequence
R3	has-part Arg1:T8 Arg2:T11	
T12	Action 228 234	shares
R4	subject Arg1:T12 Arg2:T11	
T13	Concept 245 248	70%
A1	Emphasized T13
T14	Concept 249 257	identity
R5	target Arg1:T12 Arg2:T14	
R6	in-context Arg1:T14 Arg2:T13	
R7	in-context Arg1:T14 Arg2:T10	
T15	Concept 282 289	2019-30
R8	in-context Arg1:T10 Arg2:T15	
T16	Concept 338 355	human populations
T17	Concept 402 409	viruses
